Top

Published in:

01-12-2021 | Nifedipine | Study protocol

Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM)

Authors: Elsa Lorthe, Gilles Kayem, on behalf of the TOCOPROM Study Group and the GROG (Groupe de Recherche en Obstétrique et Gynécologie)

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Abstract

Background

Preterm prelabor rupture of membranes (PPROM) before 34 weeks of gestation complicates 1% of pregnancies and accounts for one-third of preterm births. International guidelines recommend expectant management, along with antenatal steroids before 34 weeks and antibiotics. Up-to-date evidence about the risks and benefits of administering tocolysis after PPROM, however, is lacking. In theory, reducing uterine contractility could delay delivery and reduce the risks of prematurity and its adverse short- and long-term consequences, but it might also prolong fetal exposure to inflammation, infection, and acute obstetric complications, potentially associated with neonatal death or long-term sequelae. The primary objective of this study is to assess whether short-term (48 h) tocolysis reduces perinatal mortality/morbidity in PPROM at 22 to 33 completed weeks of gestation.

Methods

A randomized, double-blind, placebo-controlled, superiority trial will be performed in 29 French maternity units. Women with PPROM between 22^0/7 and 33^6/7 weeks of gestation, a singleton pregnancy, and no condition contraindicating expectant management will be randomized to receive a 48-hour oral treatment by either nifedipine or placebo (1:1 ratio). The primary outcome will be the occurrence of perinatal mortality/morbidity, a composite outcome including fetal death, neonatal death, or severe neonatal morbidity before discharge. If we assume an alpha-risk of 0.05 and beta-risk of 0.20 (i.e., a statistical power of 80%), 702 women (351 per arm) are required to show a reduction of the primary endpoint from 35% (placebo group) to 25% (nifedipine group). We plan to increase the required number of subjects by 20%, to replace any patients who leave the study early. The total number of subjects required is thus 850. Data will be analyzed by the intention-to-treat principle.

Discussion

This trial will inform practices and policies worldwide. Optimized prenatal management to improve the prognosis of infants born preterm could benefit about 50,000 women in the European Union and 40,000 in the United States each year.

Trial registration

ClinicalTrials.gov identifier: NCT03976063 (registration date June 5, 2019).

Available only for authorised users

Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101(1):178–93. https://doi.org/10.1016/s0029-7844(02)02366-9.CrossRefPubMed

Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med. 1998;338(10):663–70. https://doi.org/10.1056/NEJM199803053381006.CrossRefPubMed

Menon R, Richardson LS. Preterm prelabor rupture of the membranes: a disease of the fetal membranes. Semin Perinatol. 2017;41(7):409–19. https://doi.org/10.1053/j.semperi.2017.07.012.CrossRefPubMedPubMedCentral

Romero R, Espinoza J, Kusanovic J, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG Int J Obstet Gynaecol. 2006;113:17–42. https://doi.org/10.1111/j.1471-0528.2006.01120.x.CrossRef

Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, et al. Sterile and Microbial-associated Intra-amniotic Inflammation in Preterm Prelabor Rupture of Membranes. J Matern Fetal Neonatal Med. 2015, 1394;28(12).

Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A, et al. The Preterm prediction study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol. 2000;183(3):738–45. https://doi.org/10.1067/mob.2000.106766.CrossRefPubMed

Lorthe E. Epidemiology, risk factors and child prognosis: CNGOF Preterm premature rupture of membranes guidelines. Gynecol Obstet Fertil Senol. 2018;46(12):1004–21. https://doi.org/10.1016/j.gofs.2018.10.019.CrossRefPubMed

Schucker JL, Mercer BM. Midtrimester premature rupture of the membranes. Semin Perinatol. 1996;20(5):389–400. https://doi.org/10.1016/S0146-0005(96)80006-1.CrossRefPubMed

Pasquier J-C, Rabilloud M, Picaud J-C, Claris O, Ecochard R, Moret S, et al. Modeling the duration of the latency period after preterm premature rupture of the membranes according to maternal and pregnancy characteristics: DOMINOS study. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):157–63. https://doi.org/10.1016/j.ejogrb.2007.12.017.CrossRefPubMed

10.

Lorthe E, Ancel P-Y, Torchin H, Kaminski M, Langer B, Subtil D, et al. Impact of Latency Duration on the Prognosis of Preterm Infants after Preterm Premature Rupture of Membranes at 24 to 32 Weeks’ Gestation: A National Population-Based Cohort Study. J Pediatr. 2017;182:47–52.e2.CrossRefPubMed

11.

Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. https://doi.org/10.1016/S0140-6736(08)60074-4.CrossRefPubMedPubMedCentral

12.

Mackeen AD, Seibel-Seamon J, Muhammad J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2014;2:CD007062.

13.

Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261–9. https://doi.org/10.1016/S0140-6736(08)60136-1.CrossRefPubMed

14.

Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. 2016;215(1):103.e1–103.e14.CrossRef

15.

Lorthe E, Benhammou V, Marchand-Martin L, Pierrat V, Lebeaux C, Durox M, et al. Cohort Profile: The Etude Epidémiologique sur les Petits Ages Gestationnels-2 (EPIPAGE-2) preterm birth cohort. Int J Epidemiol.2021:dyaa282. https://doi.org/10.1093/ije/dyaa282.

16.

Goldenberg RL, McClure EM, Saleem S, Reddy UM. Infection-related stillbirths. Lancet. 2010;375(9724):1482–90. https://doi.org/10.1016/S0140-6736(09)61712-8.CrossRefPubMedPubMedCentral

17.

Pappas A, Kendrick DE, Shankaran S, Stoll BJ, Bell EF, Laptook AR, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 2014;168(2):137–47. https://doi.org/10.1001/jamapediatrics.2013.4248.CrossRefPubMedPubMedCentral

18.

Maisonneuve E, Lorthe E, Torchin H, Delorme P, Devisme L, L’Hélias LF, et al. Association of Chorioamnionitis with Cerebral Palsy at Two Years after Spontaneous Very Preterm Birth: The EPIPAGE-2 Cohort Study. J Pediatr. 2020;222:71–78.e6.CrossRefPubMed

19.

Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG Int J Obstet Gynaecol. 2005;112:32–7. https://doi.org/10.1111/j.1471-0528.2005.00582.x.CrossRef

20.

Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017;3(3):CD004735. https://doi.org/10.1002/14651858.CD004735.pub4.CrossRefPubMed

21.

Schmitz T, Sentilhes L, Lorthe E, Gallot D, Madar H, Doret-Dion M, et al. Preterm premature rupture of the membranes: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2019;236:1–6. https://doi.org/10.1016/j.ejogrb.2019.02.021.CrossRefPubMed

22.

Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol. 2020;135(3):e80.

23.

Thomson AJ. Care of Women Presenting with suspected Preterm Prelabour rupture of membranes from 24+0 weeks of gestation. BJOG Int J Obstet Gynaecol. 2019;126(9):e152–66. https://doi.org/10.1111/1471-0528.15803.CrossRef

24.

Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet. 1995;346(8985):1271–9. https://doi.org/10.1016/S0140-6736(95)91868-X.CrossRefPubMed

25.

Kenyon S, Taylor D, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet. 2001;357(9261):979–88. https://doi.org/10.1016/S0140-6736(00)04233-1.CrossRefPubMed

26.

Hutzal CE, Boyle EM, Kenyon SL, Nash JV, Winsor S, Taylor DJ, et al. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis. Am J Obstet Gynecol. 2008;199(6):620.e1–8.CrossRef

27.

Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013;12:CD001058.

28.

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. https://doi.org/10.1002/14651858.CD004454.pub3.CrossRefPubMed

29.

Christensen KK, Ingemarsson I, Leideman T, Solum T, Svenningsen N. Effect of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol. 1980;55(2):187–90.PubMed

30.

Levy DL, Warsof SL. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol. 1985;66(5):621–3.PubMed

31.

Dunlop PDM, Crowley PA, Lamont RF, Hawkins DF. Preterm ruptured membranes, no contractions. J Obstet Gynaecol. 1986;7(2):92–6. https://doi.org/10.3109/01443618609112279.CrossRef

32.

Garite TJ, Keegan KA, Freeman RK, Nageotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol. 1987;157(2):388–93. https://doi.org/10.1016/S0002-9378(87)80179-5.CrossRefPubMed

33.

Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol. 1988;159(1):216–22. https://doi.org/10.1016/0002-9378(88)90524-8.CrossRefPubMed

34.

Matsuda Y, Ikenoue T, Hokanishi H. Premature rupture of the membranes - aggressive versus conservative approach: effect of Tocolytic and antibiotic therapy. Gynecol Obstet Investig. 1993;36(2):102–7. https://doi.org/10.1159/000292605.CrossRef

35.

How HY, Cook CR, Cook VD, Miles DE, Spinnato JA. Preterm premature rupture of membranes: aggressive Tocolysis versus expectant management. J Matern Fetal Neonatal Med. 1998;7(1):8–12.CrossRef

36.

Ehsanipoor RM, Shrivastava VK, Lee RM, Chan K, Galyean AM, Garite TJ, et al. A randomized, double-masked trial of prophylactic indomethacin tocolysis versus placebo in women with premature rupture of membranes. Am J Perinatol. 2011;28(6):473–8. https://doi.org/10.1055/s-0030-1270118.CrossRefPubMed

37.

Nijman TAJ, van Vliet EOG, Naaktgeboren CA, Oude Rengerink K, de Lange TS, Bax CJ, et al. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: assessment of perinatal outcome by use of tocolysis in early labor—APOSTEL IV trial. Eur J Obstet Gynecol Reprod Biol. 2016;205:79–84. https://doi.org/10.1016/j.ejogrb.2016.08.024.CrossRefPubMed

38.

Lorthe E, Goffinet F, Marret S, Vayssiere C, Flamant C, Quere M, et al. Tocolysis after preterm premature rupture of membranes and neonatal outcome: a propensity-score analysis. Am J Obstet Gynecol. 2017;217(2):212.e1–212.e12.CrossRef

39.

Lorthe E, Moreira C, Weber T, Huusom LD, Schmidt S, Maier RF, et al. Unit policies regarding tocolysis after preterm premature rupture of membranes: association with latency, neonatal and 2-year outcomes (EPICE cohort). Sci Rep. 2020;10(1):9535. https://doi.org/10.1038/s41598-020-65201-y.CrossRefPubMedPubMedCentral

40.

Buchanan S, Crowther C, Morris J. Preterm prelabour rupture of the membranes: a survey of current practice. Aust N Z J Obstet Gynaecol. 2004;44(5):400–3. https://doi.org/10.1111/j.1479-828X.2004.00256.x.CrossRefPubMed

41.

Ramsey PS, Nuthalapaty FS, Lu G, Ramin S, Nuthalapaty ES, Ramin KD. Contemporary management of preterm premature rupture of membranes (PPROM): a survey of maternal-fetal medicine providers. Am J Obstet Gynecol. 2004;191(4):1497–502. https://doi.org/10.1016/j.ajog.2004.08.005.CrossRefPubMed

42.

Couteau C, Haumonté J-B, Bretelle F, Capelle M, D’Ercole C. Management of preterm and prelabour rupture of membranes in France. J Gynecol Obstet Biol Reprod (Paris). 2013;42(1):21–8.CrossRef

43.

Fox NS, Gelber SE, Kalish RB, Chasen ST. Contemporary practice patterns and beliefs regarding tocolysis among u.s. maternal-fetal medicine specialists. Obstet Gynecol. 2008;112(1):42–7. https://doi.org/10.1097/AOG.0b013e318176158e.CrossRefPubMed

44.

Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;5(2):CD004352. https://doi.org/10.1002/14651858.CD004352.pub3.CrossRef

45.

Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;14(6):CD002255. https://doi.org/10.1002/14651858.CD002255.pub2.CrossRef

46.

Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;6(6):CD004452. https://doi.org/10.1002/14651858.CD004452.pub3.CrossRef

47.

NICE. Preterm labour and birth | Recommendations | Guidance and guidelines | NICE [Internet]. 2015 [cité 13 avr 2017]. Disponible sur: https://www.nice.org.uk/guidance/ng25/chapter/recommendations

48.

Sentilhes L, Sénat M-V, Ancel P-Y, Azria E, Benoist G, Blanc J, et al. Prevention of spontaneous preterm birth: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2017;210:217–24. https://doi.org/10.1016/j.ejogrb.2016.12.035.CrossRefPubMed

49.

Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7. https://doi.org/10.7326/0003-4819-158-3-201302050-00583.CrossRefPubMedPubMedCentral

50.

Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330(7495):843. https://doi.org/10.1136/bmj.330.7495.843.CrossRefPubMedPubMedCentral

51.

Webbe JWH, Duffy JMN, Afonso E, Al-Muzaffar I, Brunton G, Greenough A, et al. Core outcomes in neonatology: development of a core outcome set for neonatal research. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):425–31. https://doi.org/10.1136/archdischild-2019-317501.CrossRefPubMed

52.

Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016;387(10017):444–52. https://doi.org/10.1016/S0140-6736(15)00724-2.CrossRefPubMed

53.

Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–9. https://doi.org/10.1164/ajrccm.163.7.2011060.CrossRefPubMed

54.

Papile L-A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–34. https://doi.org/10.1016/S0022-3476(78)80282-0.CrossRefPubMed

55.

Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110–24. https://doi.org/10.1016/S1474-4422(08)70294-1.CrossRefPubMedPubMedCentral

56.

Shah BA, Padbury JF. Neonatal sepsis. Virulence. 2014;5(1):170–8. https://doi.org/10.4161/viru.26906.CrossRefPubMed

57.

Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7. https://doi.org/10.1097/00000658-197801000-00001.CrossRefPubMedPubMedCentral

58.

Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9. https://doi.org/10.1001/archopht.123.7.991.CrossRef

59.

Mackeen AD, Packard RE, Ota E, Speer L. Antibiotic regimens for postpartum endometritis. Cochrane Database Syst Rev. 2015;2:CD001067.

60.

Young L, Berg M, Soll R. Prophylactic barbiturate use for the prevention of morbidity and mortality following perinatal asphyxia. Cochrane Database Syst Rev. 2016;5(5):CD001240. https://doi.org/10.1002/14651858.CD001240.pub3.CrossRef

61.

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset Sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002;110(2):285–91. https://doi.org/10.1542/peds.110.2.285.CrossRefPubMed

62.

Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy report of the quality standards Subcommittee of the American Academy of neurology and the practice Committee of the Child Neurology Society. Neurology. 2004;62(6):851–63. https://doi.org/10.1212/01.WNL.0000117981.35364.1B.CrossRefPubMed

63.

Ghassabian A, Sundaram R, Bell E, Bello SC, Kus C, Yeung E. Gross motor milestones and subsequent development. Pediatrics. 2016;138(1):e20154372. https://doi.org/10.1542/peds.2015-4372.CrossRefPubMedPubMedCentral

64.

Pierrat V, Marchand-Martin L, Arnaud C, Kaminski M, Resche-Rigon M, Lebeaux C, et al. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: the EPIPAGE-2 cohort study. BMJ. 2017;358:j3448.CrossRefPubMedPubMedCentral

65.

Flamant C, Branger B, Nguyen The Tich S, de La Rochebrochard E, Savagner C, Berlie I, et al. Parent-Completed Developmental Screening in Premature Children: A Valid Tool for Follow-Up Programs. PLoS One. 6(5):e20004.

66.

Iliodromiti S, Mackay DF, Smith GCS, Pell JP, Nelson SM. Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. Lancet. 2014;384(9956):1749–55. https://doi.org/10.1016/S0140-6736(14)61135-1.CrossRefPubMed

67.

Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.

68.

Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c332. https://doi.org/10.1136/bmj.c332.CrossRefPubMedPubMedCentral

Title: Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM)
Authors: Elsa Lorthe
Gilles Kayem
on behalf of the TOCOPROM Study Group and the GROG (Groupe de Recherche en Obstétrique et Gynécologie)
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Nifedipine
Premature Birth
Published in: BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-021-04047-2

2024 ASCO Annual Meeting

Springer Medicine

Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM)

Abstract

Background

Methods

Discussion

Trial registration

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Identifying target behaviors for weight management interventions for women who are overweight during pregnancy and the postpartum period: a qualitative study informed by the Behaviour Change Wheel

Pattern of internet use for pregnancy-related information and its predictors among women visiting primary healthcare in Qatar: a cross-sectional study

The predictive value of serial serum estradiol and serial endometrial volume on endometrial receptivity on assisted reproductive technology cycles

Educational behaviors of pregnant women in the Bronx during Zika’s International emerging epidemic: “First mom … and then I’d Google. And then my doctor”

Psychometric properties of the Persian version of delivery fear scale (DFS) in Iran

Youth-centered maternity care: a binational qualitative comparison of the experiences and perspectives of Latina adolescents and healthcare providers